Psyence Biomedical Ltd. Common Shares Financial Flexibility Index
Psyence Biomedical Ltd. Common Shares financial flexibility index. Psyence Biomedical Ltd. Common Shares (PBM) has a Financial Flexibility Index of -0.05x as of December 2023. Free cash flow of $-658.20 (operating CF $-662.00 minus capex $3.80) represents 0% of total liabilities ($12.10K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Psyence Biomedical Ltd. Common Shares (2022–2025)
Financial flexibility index of Psyence Biomedical Ltd. Common Shares from 2022 to 2025. Historical Financial Flexibility Index trend for Psyence Biomedical Ltd. Common Shares across 4 annual periods. Check PBM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Psyence Biomedical Ltd. Common Shares Financial Flexibility Index by Year (2022–2025)
Psyence Biomedical Ltd. Common Shares financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Psyence Biomedical Ltd. Common Shares. For the full cash flow conversion analysis, see cash flow conversion of Psyence Biomedical Ltd. Common Shares.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.27x | $-3.72 Million | $-3.73 Million | $594.37K | ▼ -2480.2% |
| 2024 | -0.24x | $-2.94 Million | $-2.95 Million | $12.10 Million | ▼ -567.0% |
| 2023 | -0.04x | $-519.60K | $-519.60K | $14.27 Million | ▲ +57.3% |
| 2022 | -0.09x | $-1.40 Million | $-1.40 Million | $16.38 Million | — |